Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-03 Sale | 2024-01-05 4:49 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 5,365 | $29.46 | $158,053 | 40,585 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 5:23 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 2,427 | $37.21 | $90,309 | 15,404 (Direct) | View |
| 2022-01-01 Sale | 2022-03-03 7:38 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 1,013 | $112.24 | $113,699 | 36,677 (Direct) | View |
| 2021-09-07 Sale | 2021-09-09 5:38 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,482 | $180.12 | $627,178 | 12,451 (Direct) | View |
| 2021-08-30 Sale | 2021-09-01 7:30 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 30,000 | $159.45 | $4,783,538 | 122,550 (Direct) | View |
| 2021-08-05 Sale | 2021-08-06 6:17 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 20,000 | $151.05 | $3,021,056 | 70,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 69,944 | $0 | 110,529 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 5:28 pm | 2024-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,062 | $0 | 49,014 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:20 pm | N/A 2033-02-28 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 66,318 | $0 | 81,722 (Direct) | View |
| 2023-01-01 Exercise | 2023-01-04 8:29 pm | 2023-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,062 | $0 | 23,957 (Direct) | View |
| 2022-03-01 Option Award(A) | 2022-03-04 9:04 pm | N/A 2032-02-28 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 18,600 | $0 | 18,600 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:38 pm | N/A 2032-02-28 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 12,720 | $0 | 36,677 (Direct) | View |
| 2022-01-01 Exercise | 2022-03-03 7:38 pm | 2022-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,062 | $0 | 36,677 (Direct) | View |
| 2021-09-07 Exercise | 2021-09-09 5:38 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,482 | $14.58 | 12,451 (Direct) | View |
| 2021-09-07 Exercise | 2021-09-09 5:38 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 3,482 | $0 | 12,451 (Direct) | View |
| 2021-08-31 Exercise | 2021-09-01 7:30 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 1,817 | $14.58 | 122,550 (Direct) | View |
| 2021-08-30 Exercise | 2021-09-01 7:30 pm | N/A 2028-10-31 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 30,000 | $0 | 122,550 (Direct) | View |
| 2021-08-30 Exercise | 2021-09-01 7:30 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 28,183 | $19.27 | 122,550 (Direct) | View |
| 2021-08-05 Exercise | 2021-08-06 6:17 pm | N/A 2028-10-31 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 20,000 | $0 | 70,000 (Direct) | View |
| 2021-08-05 Exercise | 2021-08-06 6:17 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 20,000 | $19.27 | 70,000 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 5:49 pm | N/A 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 85,750 | $0 | 85,750 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 5:28 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |